Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6 vs 12 Cycles Temozolomide in High Grade Glioma
NCT03633552Phase 3Unknown
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in glioblastoma multiforme (GBM), anaplastic astrocytoma (AA), sponsored by Mashhad University of Medical Sciences. Status: unknown.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT03633552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633552.